Selected publications
-
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
Cancer Research.
2019
Academic Article
GET IT
Times cited: 5 -
Resistance to TRK inhibition mediated by convergent MAPK pathway activation.
Nature Medicine.
2019
Letter
GET IT
Times cited: 2 -
Learning all that we can from MyPathway.
Journal of Clinical Oncology.
2018
Academic Article
GET IT
Times cited: 1 -
Genome doubling shapes the evolution and prognosis of advanced cancers.
Nature Genetics.
2018
Academic Article
GET IT
Times cited: 22 -
Accelerating discovery of functional mutant alleles in cancer.
Cancer Discovery.
2018
Academic Article
GET IT
Times cited: 40 -
Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
Annual Review of Medicine.
2018
Academic Article
GET IT
Times cited: 15 -
A next-generation TRK kinase inhibitor overcomes acquired resistance to prior trk kinase inhibition in patients with TRK fusion-positive solid tumors.
Cancer Discovery.
2017
Academic Article
GET IT
Times cited: 70 -
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers.
OncoTargets and Therapy.
2017
Review
GET IT
Times cited: 17 -
Niraparib in recurrent ovarian cancer.
New England Journal of Medicine.
2017
Article
GET IT
Times cited: 5 -
Precision oncology: Charting a path forward to broader deployment of genomic profiling.
PLoS Medicine.
2017
Academic Article
GET IT
Times cited: 6 -
Genome-driven paradigm for the development of selective fibroblast growth factor receptor inhibitors.
Journal of Clinical Oncology.
2017
Academic Article
GET IT
Times cited: 4 -
Oncologist use and perception of large panel next-generation tumor sequencing.
Annals of Oncology.
2017
Academic Article
GET IT
Times cited: 9 -
Quantifying the benefits of genome-driven oncology.
Cancer Discovery.
2017
Academic Article
GET IT
Times cited: 4 - Picking the right patient for human epidermal growth factor receptor 3 - Targeted therapy in platinum-resistant ovarian cancer. Journal of Clinical Oncology. 2016 Academic Article GET IT